EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

James B. Hoying, PhD, FAHA

Chief, Division of Cardiovascular Therapeutics, Cardiovascular Innovation Institute at University of Louisville

Profile

James (Jay) B. Hoying, Ph.D. FAHA is the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and Professor in the Department Physiology at the University of Louisville. He has over 25 years of experience, having published over 116 papers and book chapters, in basic and applied biological sciences with a focus in vascular biology and repair. He holds a number of patents related to repairing and manipulating capillaries and cell-based therapies. He is President and co-founder of Angiomics, Inc., a biotech company advancing vascular health through its patented isolated microvessel technology. He is also Chief Scientist and a Partner of Advanced Solutions Life Sciences, a Louisville company advancing 3D bioprinting and tissue fabrication. Before moving to the CII in 2007, Dr. Hoying was an Associate Professor in the Division of Biomedical Engineering in the Arizona Research Laboratories at the University of Arizona, as well as Co-founder and Co-Director of the Genomics Research Laboratory (GRL). He received his Bachelor’s and Master’s degrees in Biology and Molecular Biology from Case Western Reserve University, and his PhD in Cardiovascular Physiology from the University of Arizona. Prior to joining the faculty at the University of Arizona, Dr. Hoying was a New Investigator in the National Institutes of Health Program of Excellence in Molecular Biology of the Heart and Lung (POEMB) in the Department of Molecular Genetics at the University of Cincinnati. He currently serves on the Editorial staff of two national scientific journals and the review boards of a number of other national and international journals. He routinely reviews grant proposals for the National Institutes of Health, the Veterans Affairs, the American Heart Association, and international funding agencies. He is a Fellow of the American Heart Association.

Agenda Sessions